1. Home
  2. ACU vs CGTX Comparison

ACU vs CGTX Comparison

Compare ACU & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$36.71

Market Cap

145.9M

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.74

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
CGTX
Founded
1867
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.9M
158.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ACU
CGTX
Price
$36.71
$1.74
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.88
AVG Volume (30 Days)
9.4K
978.2K
Earning Date
10-21-2025
11-06-2025
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$194,960,991.00
N/A
Revenue This Year
$3.05
N/A
Revenue Next Year
$4.20
N/A
P/E Ratio
$15.13
N/A
Revenue Growth
2.35
N/A
52 Week Low
$34.35
$0.22
52 Week High
$45.25
$3.83

Technical Indicators

Market Signals
Indicator
ACU
CGTX
Relative Strength Index (RSI) 44.95 55.50
Support Level $36.24 $1.69
Resistance Level $38.09 $1.81
Average True Range (ATR) 0.81 0.13
MACD 0.15 0.03
Stochastic Oscillator 45.30 87.22

Price Performance

Historical Comparison
ACU
CGTX

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: